FDA says women can get abortion pill via telemedicine pressherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressherald.com Daily Mail and Mail on Sunday newspapers.
A day after gutting restrictions on abortion pills that studies have shown carry significant risks for women, the Food and Drug Administration called for states to halt the use of the Johnson & Johnson COVID-19 vaccine due to six cases of women developing a rare blood clot within two weeks of receiving the dose. As of today, an estimated 7 million Americans have received the Johnson & Johnson vaccine.
The two abortifacient drugs on which the FDA loosened restrictions are mifepristone and misoprostol. On Monday, acting FDA Commissioner Janet Woodcock instructed the American College of Obstetricians and Gynecologists that providers will be permitted to administer the drugs through telemedicine, as well as through the mail.
email article
The FDA will allow mifepristone (Mifeprex) to be dispensed by mail during the pandemic, temporarily lifting previous requirements that it be given to patients in person, the agency said on Monday.
In a letter to the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM), acting FDA Commissioner Janet Woodcock, MD, stated that the agency will exercise enforcement discretion regarding the in-person dispensing requirement for mifepristone, as long as the president s declaration of a public health emergency for COVID-19 remains in place.
Essentially, FDA won t enforce the in-person prescribing requirement that s part of the drug s risk management program.
Abortion Pill via Mail OKed by US Agency snopes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from snopes.com Daily Mail and Mail on Sunday newspapers.
FDA pauses enforcement of in-person dispensing requirement for abortion pill
Getty Images/PhotoAlto
The FDA will pause enforcement of a rule requiring mifepristone be dispensed in person, citing the potential risk of COVID-19 exposure to patients and providers.
Mifepristone, which is used to end early pregnancies and for miscarriage management, can now be mailed to patients by certified prescribers.
Medical groups have long argued that the in-person dispensing requirement is unnecessary because the drug is safe. During COVID-19, the American College of Obstetricians and Gynecologists (ACOG) ramped up their efforts to have the requirements paused at least temporarily so patients would not have to risk exposure to the virus at the pharmacy, doctor s office or public transportation.